The LDL-c challenge in high cardiovascular risk - Integrating innovative therapies in clinical management

Episodes 1-5 of 5

• 

  RestartResume

  The evolving need and challenges to reach LDL-c targets in high-risk patients 
  

  RestartResume

  The evolving need and challenges to reach LDL-c targets in high-risk patients 
  

  MinuteCE®

  The evolving need and challenges to reach LDL-c targets in high-risk patients 
  

  1.00 program credit

  • 

    

    Prof. Kausik Ray, MBChB, MD, MPhil

  1.00 program credit

• 

  RestartResume

  PCSK9i: Benefits across the spectrum of cardiovascular disease 
  

  RestartResume

  PCSK9i: Benefits across the spectrum of cardiovascular disease 
  

  MinuteCE®

  PCSK9i: Benefits across the spectrum of cardiovascular disease 
  

  1.00 program credit

  • 

    

    Fabrice Martens, MD, PhD, FESC

  1.00 program credit

• 

  RestartResume

  Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi 
  

  RestartResume

  Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi 
  

  MinuteCE®

  Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi 
  

  1.00 program credit

  • 

    

    Erin D. Michos, MD, MHS, FACC, FAHA, FASE

  1.00 program credit

• 

  RestartResume

  Oral cholesterol-lowering therapies: The basis of prevention 
  

  RestartResume

  Oral cholesterol-lowering therapies: The basis of prevention 
  

  MinuteCE®

  Oral cholesterol-lowering therapies: The basis of prevention 
  

  1.00 program credit

  • 

    

    Lale Tokgözoğlu, MD

  1.00 program credit

• 

  MinuteCE®

  The LDL-c challenge in high cardiovascular risk - Integrating innovative therapies in clinical management

  1.00 credit 4 episodes

  • 

    

    Prof. Kausik Ray, MBChB, MD, MPhil

  • 

    

    Lale Tokgözoğlu, MD

  • 

    

    Fabrice Martens, MD, PhD, FESC

  • 

    

    Erin D. Michos, MD, MHS, FACC, FAHA, FASE

  1.00 credit 4 episodes